{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:56:41Z","timestamp":1794013001880,"version":"4.8.0"},"reference-count":164,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30830"],"award-info":[{"award-number":["2022JJ30830"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["20201179"],"award-info":[{"award-number":["20201179"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070175"],"award-info":[{"award-number":["82070175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.gendis.2023.02.039","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T19:18:29Z","timestamp":1680203909000},"page":"234-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":218,"title":["HIF-1\u03b1 signaling: Essential roles in tumorigenesis and implications in targeted therapies"],"prefix":"10.1016","volume":"11","author":[{"given":"Yan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib2","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emm.2004.1","article-title":"Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions","volume":"36","author":"Lee","year":"2004","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ccell.2018.11.009","article-title":"The roles of initiating truncal mutations in human cancers: the order of mutations and tumor cell type matters","volume":"35","author":"Levine","year":"2019","journal-title":"Cancer Cell"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2023.02.039_bib5","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/annonc\/mdl443","article-title":"Epidemiology of hematological malignancies","volume":"18","author":"Rodriguez-Abreu","year":"2007","journal-title":"Ann Oncol"},{"issue":"9936","key":"10.1016\/j.gendis.2023.02.039_bib6","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","article-title":"Myelodysplastic syndromes","volume":"383","author":"Ad\u00e8s","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib7","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.gendis.2023.02.039_bib8","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.1002\/ajh.25201","article-title":"Non-transferrin-bound iron and oxidative stress during allogeneic hemopoietic stem cell transplantation in patients with or without iron overload","volume":"93","author":"Duca","year":"2018","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.gendis.2023.02.039_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22900","article-title":"The current knowledge concerning solid cancer and therapy","volume":"35","author":"Najafi","year":"2021","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14712598.2016.1133582","article-title":"Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact","volume":"16","author":"Rouault-Pierre","year":"2016","journal-title":"Expet Opin Biol Ther"},{"issue":"7777","key":"10.1016\/j.gendis.2023.02.039_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/d41586-019-02963-0","article-title":"Biologists who decoded how cells sense oxygen win medicine Nobel","volume":"574","author":"Ledford","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib13","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5603\/EP.a2020.0064","article-title":"An overview of biological research on hypoxia-inducible factors (HIFs)","volume":"71","author":"Liu","year":"2020","journal-title":"Endokrynol Pol"},{"issue":"19","key":"10.1016\/j.gendis.2023.02.039_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-\u03baB activation: a review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/BJ20090120","article-title":"The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction","volume":"424","author":"Tanaka","year":"2009","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.celrep.2014.02.011","article-title":"Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia","volume":"6","author":"Zhang","year":"2014","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib18","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3892\/mmr.2015.3689","article-title":"Progress on hypoxia-inducible factor-3: its structure, gene regulation and biological function (Review)","volume":"12","author":"Yang","year":"2015","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409238.2013.838205","article-title":"Transcriptional regulation by hypoxia inducible factors","volume":"49","author":"Dengler","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.gendis.2023.02.039_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cbpc.2010.11.005","article-title":"Molecular and functional characterization of aryl hydrocarbon receptor nuclear translocator 1 (ARNT1) and ARNT2 in chicken (Gallus gallus)","volume":"153","author":"Lee","year":"2011","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"5060","key":"10.1016\/j.gendis.2023.02.039_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.256.5060.1193","article-title":"Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor","volume":"256","author":"Reyes","year":"1992","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1124\/mol.106.027029","article-title":"Hypoxia-inducible factor-1 (HIF-1)","volume":"70","author":"Ke","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"26","key":"10.1016\/j.gendis.2023.02.039_bib24","doi-asserted-by":"crossref","first-page":"15504","DOI":"10.1073\/pnas.2533374100","article-title":"Structural basis for PAS domain heterodimerization in the basic helix\u2013loop\u2013helix\u2013PAS transcription factor hypoxia-inducible factor","volume":"100","author":"Erbel","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.gendis.2023.02.039_bib25","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1074\/jbc.M310041200","article-title":"Contribution of the Per\/Arnt\/Sim (PAS) domains to DNA binding by the basic helix-loop-helix PAS transcriptional regulators","volume":"279","author":"Chapman-Smith","year":"2004","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.gendis.2023.02.039_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/17460441.2019.1613370","article-title":"The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy","volume":"14","author":"Albadari","year":"2019","journal-title":"Expet Opin Drug Discov"},{"issue":"30","key":"10.1016\/j.gendis.2023.02.039_bib27","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","article-title":"Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1","volume":"271","author":"Jiang","year":"1996","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.gendis.2023.02.039_bib28","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2- dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"10.1016\/j.gendis.2023.02.039_bib29","doi-asserted-by":"crossref","first-page":"19253","DOI":"10.1074\/jbc.272.31.19253","article-title":"Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension","volume":"272","author":"Jiang","year":"1997","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.gendis.2023.02.039_bib30","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1073\/pnas.082117899","article-title":"Structural basis for recruitment of CBP\/p300 by hypoxia-inducible factor-1 alpha","volume":"99","author":"Freedman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1016\/j.gendis.2023.02.039_bib31","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1101\/gad.924501","article-title":"FIH-1:a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity","volume":"15","author":"Mahon","year":"2001","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol Cell"},{"issue":"5516","key":"10.1016\/j.gendis.2023.02.039_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2- regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"issue":"6892","key":"10.1016\/j.gendis.2023.02.039_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature00767","article-title":"Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL","volume":"417","author":"Hon","year":"2002","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib35","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor","volume":"16","author":"Lando","year":"2002","journal-title":"Genes Dev"},{"issue":"8","key":"10.1016\/j.gendis.2023.02.039_bib36","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1073\/pnas.082121399","article-title":"Structural basis for Hif-1 alpha\/CBP recognition in the cellular hypoxic response","volume":"99","author":"Dames","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.gendis.2023.02.039_bib40","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/emboj.2012.125","article-title":"The updated biology of hypoxia-inducible factor","volume":"31","author":"Greer","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.gendis.2023.02.039_bib41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fonc.2020.00486","article-title":"Hypoxia-induced epithelial-mesenchymal transition in cancers: HIF-1\u03b1 and beyond","volume":"10","author":"Tam","year":"2020","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib42","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s12272-017-0971-5","article-title":"A positive circuit of VEGF increases Glut-1 expression by increasing HIF-1\u03b1 gene expression in human retinal endothelial cells","volume":"40","author":"Choi","year":"2017","journal-title":"Arch Pharm Res (Seoul)"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep4.1175","article-title":"Loss of hypoxia inducible factor-1\u03b1 aggravates \u03b3\u03b4 T-cell-mediated inflammation during acetaminophen-induced liver injury","volume":"2","author":"Suzuki","year":"2018","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib44","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ymthe.2021.02.017","article-title":"WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1\u03b1 accumulation in Myc-dependent and independent pathways","volume":"29","author":"Chen","year":"2021","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib45","doi-asserted-by":"crossref","first-page":"11898","DOI":"10.1080\/21655979.2021.1999552","article-title":"Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p\/HIF-1\u03b1 axis","volume":"12","author":"Tian","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.gendis.2023.02.039_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109780","article-title":"microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1\u03b1 expression","volume":"355","author":"Peng","year":"2022","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.gendis.2023.02.039_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.642352","article-title":"Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective","volume":"9","author":"Akil","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib48","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yexcr.2017.04.030","article-title":"The interplay between the cellular hypoxic response and Notch signaling","volume":"356","author":"Landor","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.gendis.2023.02.039_bib50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/cells10010094","article-title":"Context matters: Notch signatures and pathway in cancer progression and metastasis","volume":"10","author":"Misiorek","year":"2021","journal-title":"Cells"},{"issue":"46","key":"10.1016\/j.gendis.2023.02.039_bib51","doi-asserted-by":"crossref","first-page":"E10869","DOI":"10.1073\/pnas.1808314115","article-title":"p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression","volume":"115","author":"Amelio","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.gendis.2023.02.039_bib52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tibs.2015.04.007","article-title":"The p53 family and the hypoxia-inducible factors (HIFs):determinants of cancer progression","volume":"40","author":"Amelio","year":"2015","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.gendis.2023.02.039_bib54","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ymthe.2019.05.017","article-title":"Hypoxia induces drug resistance in colorectal cancer through the HIF-1\u03b1\/miR-338-5p\/IL-6 feedback loop","volume":"27","author":"Xu","year":"2019","journal-title":"Mol Ther"},{"issue":"14","key":"10.1016\/j.gendis.2023.02.039_bib55","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.onc.1210008","article-title":"Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance","volume":"26","author":"Kilic","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib56","doi-asserted-by":"crossref","first-page":"8897","DOI":"10.1080\/21655979.2021.1988368","article-title":"LRG1 promotes hypoxia-induced cardiomyocyte apoptosis and autophagy by regulating hypoxia-inducible factor-1\u03b1","volume":"12","author":"Feng","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.gendis.2023.02.039_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11635","article-title":"HIF-1\u03b1-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity","volume":"7","author":"Semba","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib58","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bbrc.2018.04.177","article-title":"ROS mediated EGFR\/MEK\/ERK\/HIF-1\u03b1 Loop Regulates Glucose metabolism in pancreatic cancer","volume":"500","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.gendis.2023.02.039_bib59","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cbin.11654","article-title":"The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis","volume":"45","author":"Hu","year":"2021","journal-title":"Cell Biol Int"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib60","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.gendis.2023.02.039_bib61","article-title":"PPAR\u03b3 regulated CIDEA affects pro-apoptotic responses in glioblastoma","volume":"1","author":"Chatterjee","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2023.02.039_bib62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","article-title":"Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1\u03b1\/PPAR-\u03b3\/PKM2-mediated glycolysis","volume":"39","author":"Feng","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib63","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/ijms19041264","article-title":"Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2","volume":"19","author":"Peach","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib64","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.tips.2015.03.003","article-title":"Hypoxia-inducible factors in cancer stem cells and inflammation","volume":"36","author":"Peng","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.gendis.2023.02.039_bib65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biocel.2017.10.016","article-title":"PIM kinases: from survival factors to regulators of cell motility","volume":"93","author":"Santio","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"issue":"32","key":"10.1016\/j.gendis.2023.02.039_bib66","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1038\/s41388-021-01915-1","article-title":"Direct phosphorylation and stabilization of HIF-1\u03b1 by PIM1 kinase drives angiogenesis in solid tumors","volume":"40","author":"Casillas","year":"2021","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib67","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1002\/1878-0261.13044","article-title":"Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia-inducible factor-1\u03b1 in colorectal cancer","volume":"15","author":"Fang","year":"2021","journal-title":"Mol Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib68","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1002\/jcp.27154","article-title":"Identification of a five-gene signature with prognostic value in colorectal cancer","volume":"234","author":"Sun","year":"2019","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/j.gendis.2023.02.039_bib69","first-page":"882","article-title":"Profiling of tumor microenvironment components identifies five stroma-related genes with prognostic implications in colorectal cancer","volume":"37","author":"Liu","year":"2022","journal-title":"Cancer Biother Radiopharm"},{"issue":"9","key":"10.1016\/j.gendis.2023.02.039_bib70","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/cells8091083","article-title":"Improving cancer immunotherapy by targeting the hypoxic tumor microenvironment: new opportunities and challenges","volume":"8","author":"Noman","year":"2019","journal-title":"Cells"},{"issue":"45","key":"10.1016\/j.gendis.2023.02.039_bib71","doi-asserted-by":"crossref","first-page":"E6215","DOI":"10.1073\/pnas.1520032112","article-title":"HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.gendis.2023.02.039_bib72","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/2326-6066.CIR-18-0507","article-title":"Hypoxia-induced VISTA promotes the suppressive function of myeloid-derived suppressor cells in the tumor microenvironment","volume":"7","author":"Deng","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"11","key":"10.1016\/j.gendis.2023.02.039_bib73","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.4251\/wjgo.v13.i11.1725","article-title":"Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma","volume":"13","author":"Deng","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.gendis.2023.02.039_bib74","article-title":"PD-1+ CD4 T cell immune response is mediated by HIF-1\u03b1\/NFATc1 pathway after P. yoelii infection","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib75","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/tox.23369","article-title":"Fenofibrate inhibits hypoxia-inducible factor-1 alpha and carbonic anhydrase expression through activation of AMP-activated protein kinase\/HO-1\/Sirt1 pathway in glioblastoma cells","volume":"36","author":"Lin","year":"2021","journal-title":"Environ Toxicol"},{"key":"10.1016\/j.gendis.2023.02.039_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174845","article-title":"Suppression of the doxorubicin response by hypoxia-inducible factor-1\u03b1 is strictly dependent on oxygen concentrations under hypoxic conditions","volume":"920","author":"Osada-Oka","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib77","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/0284186X.2017.1301680","article-title":"HIF-1 in cancer therapy: two decade long story of a transcription factor","volume":"56","author":"Soni","year":"2017","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2023.02.039_bib78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.gendis.2023.02.039_bib79","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib80","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","article-title":"Hypoxia-inducible factors: master regulators of cancer progression","volume":"2","author":"Schito","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.gendis.2023.02.039_bib81","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-030-34461-0_18","article-title":"Hypoxia compromises anti-cancer immune responses","volume":"1232","author":"Multhoff","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"13","key":"10.1016\/j.gendis.2023.02.039_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109757","article-title":"HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells","volume":"36","author":"Lu","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2023.02.039_bib83","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2019.06.016","article-title":"HIF-1\u03b1-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib","volume":"460","author":"Song","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.gendis.2023.02.039_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11658-018-0077-1","article-title":"HIF-1\u03b1 promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8-NF-\u03baB axis","volume":"23","author":"Feng","year":"2018","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1139\/bcb-2020-0090","article-title":"hCINAP is potentially a direct target gene of HIF-1 and is required for hypoxia-induced EMT and apoptosis in cervical cancer cells","volume":"99","author":"Zhang","year":"2021","journal-title":"Biochem Cell Biol"},{"issue":"26","key":"10.1016\/j.gendis.2023.02.039_bib86","doi-asserted-by":"crossref","first-page":"E5990","DOI":"10.1073\/pnas.1801348115","article-title":"Hypoxic tumor microenvironment activates GLI2 via HIF-1\u03b1 and TGF-\u03b22 to promote chemoresistance in colorectal cancer","volume":"115","author":"Tang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2023.02.039_bib87","article-title":"Hypoxia tumor microenvironment activates GLI2 through HIF-1\u03b1 and TGF-\u03b22 to promote chemotherapy resistance of colorectal cancer","volume":"2022","author":"Huang","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"3","key":"10.1016\/j.gendis.2023.02.039_bib88","first-page":"1759","article-title":"The HIF-1\u03b1\/miR-224-3p\/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia-induced protective autophagy in glioblastoma and astrocytoma","volume":"41","author":"Huang","year":"2019","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib89","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/07853890.2022.2071977","article-title":"Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy","volume":"54","author":"Xiang","year":"2022","journal-title":"Ann Med"},{"issue":"9","key":"10.1016\/j.gendis.2023.02.039_bib90","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00210-020-01885-3","article-title":"Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways","volume":"393","author":"Jaidee","year":"2020","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.gendis.2023.02.039_bib91","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.blre.2019.04.003","article-title":"Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: reconciling biological concepts and clinical issues","volume":"36","author":"Gaudichon","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.gendis.2023.02.039_bib92","article-title":"Deferoxamine inhibits acute lymphoblastic leukemia progression through repression of ROS\/HIF-1 \u03b1, Wnt\/\u03b2-catenin, and p38MAPK\/ERK pathways","volume":"2022","author":"You","year":"2022","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2023.02.039_bib93","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3390\/ijms23031728","article-title":"Transcriptional regulation of Yin-Yang 1 expression through the hypoxia inducible factor-1 in pediatric acute lymphoblastic leukemia","volume":"23","author":"Antonio-Andres","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib94","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/bloodadvances.2020002832","article-title":"Hypoxia favors chemoresistance in T-ALL through an HIF1\u03b1-mediated mTORC1 inhibition loop","volume":"5","author":"Fahy","year":"2021","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib95","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3390\/cancers13122883","article-title":"Targeting HIF-1\u03b1 regulatory pathways as a strategy to hamper tumor-microenvironment interactions in CLL","volume":"13","author":"Vitale","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib96","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3324\/haematol.2019.217430","article-title":"HIF-1\u03b1 is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia","volume":"105","author":"Griggio","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41375-019-0513-x","article-title":"Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL","volume":"34","author":"Yosifov","year":"2020","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib98","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190262","article-title":"EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine","volume":"10","author":"Valsecchi","year":"2020","journal-title":"Open Biol"},{"key":"10.1016\/j.gendis.2023.02.039_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109094","article-title":"PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1\u03b1 expression","volume":"242","author":"Zhu","year":"2022","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib100","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/ijlh.13512","article-title":"CXCL2 benefits acute myeloid leukemia cells in hypoxia","volume":"43","author":"Li","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib101","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/cbin.11246","article-title":"HIF-1\u03b1 forms regulatory loop with YAP to coordinate hypoxia-induced adriamycin resistance in acute myeloid leukemia cells","volume":"44","author":"Zhu","year":"2020","journal-title":"Cell Biol Int"},{"issue":"14","key":"10.1016\/j.gendis.2023.02.039_bib102","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41388-020-1201-z","article-title":"Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1\u03b1 with echinomycin","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib103","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1172\/JCI133187","article-title":"Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia","volume":"130","author":"Waclawiczek","year":"2020","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib104","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5483\/BMBRep.2022-0095","article-title":"Hypoxia-inducible factor 1\u03b1 inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells","volume":"56","author":"Tsubaki","year":"2023","journal-title":"BMB Rep"},{"key":"10.1016\/j.gendis.2023.02.039_bib105","article-title":"Combined effects of 2-methoxyestradiol (hypoxia-inducible factor 1 \u03b1 inhibitor) and dasatinib (a second-generation tyrosine kinase inhibitor) on chronic myelocytic leukemia cells","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Immunol Res"},{"issue":"51","key":"10.1016\/j.gendis.2023.02.039_bib106","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107220118","article-title":"Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance","volume":"118","author":"Guo","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.gendis.2023.02.039_bib107","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s10495-022-01741-0","article-title":"Phosphodiesterase 5 inhibitor sildenafil potentiates the antitumor activity of cisplatin by ROS-mediated apoptosis: a role of deregulated glucose metabolism","volume":"27","author":"Rawat","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.gendis.2023.02.039_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628329","article-title":"Methyl jasmonate cytotoxicity and chemosensitization of T cell lymphoma in vitro is facilitated by HK 2, HIF-1\u03b1, and Hsp70: implication of altered regulation of cell survival, pH homeostasis, mitochondrial functions","volume":"12","author":"Goel","year":"2021","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.gendis.2023.02.039_bib109","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/exd.14133","article-title":"Systemic chemotherapy promotes HIF-1\u03b1-mediated glycolysis and IL-17F pathways in cutaneous T-cell lymphoma","volume":"29","author":"Wang","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.gendis.2023.02.039_bib110","article-title":"Targeting the endothelin-1 receptors curtails tumor growth and angiogenesis in multiple myeloma","volume":"10","author":"Russignan","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112280","article-title":"Dysregulation of LncRNA ANRIL mediated by miR-411\u20133p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1\u03b1","volume":"396","author":"Wang","year":"2020","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.gendis.2023.02.039_bib112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-8722-6-3","article-title":"Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells","volume":"6","author":"Zou","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"11","key":"10.1016\/j.gendis.2023.02.039_bib113","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1080\/10428194.2018.1448083","article-title":"Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene","volume":"59","author":"Antonio-Andr\u00e9s","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib114","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3324\/haematol.2019.246330","article-title":"HIF-1\u03b1: a potential treatment target in chronic lymphocytic leukemia","volume":"105","author":"Seiffert","year":"2020","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.gendis.2023.02.039_bib115","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2015-07-657056","article-title":"HIF-1\u03b1 regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment","volume":"127","author":"Valsecchi","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/bloodadvances.2016000984","article-title":"Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment","volume":"1","author":"Serra","year":"2016","journal-title":"Blood Adv"},{"issue":"629","key":"10.1016\/j.gendis.2023.02.039_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh2548","article-title":"Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice","volume":"14","author":"Zhu","year":"2022","journal-title":"Sci Transl Med"},{"issue":"20","key":"10.1016\/j.gendis.2023.02.039_bib118","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1038\/s41388-018-0151-1","article-title":"HIF1\u03b1 drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia","volume":"37","author":"Abdul-Aziz","year":"2018","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib119","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/emmm.201303065","article-title":"HIF factors cooperate with PML-RAR\u03b1 to promote acute promyelocytic leukemia progression and relapse","volume":"6","author":"Coltella","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"8","key":"10.1016\/j.gendis.2023.02.039_bib120","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ajh.24415","article-title":"Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia","volume":"91","author":"Badar","year":"2016","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib121","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.stemcr.2018.11.023","article-title":"Hif-1\u03b1 deletion may lead to adverse treatment effect in a mouse model ofMLL-AF9-driven AML","volume":"12","author":"Velasco-Hernandez","year":"2019","journal-title":"Stem Cell Rep"},{"issue":"24","key":"10.1016\/j.gendis.2023.02.039_bib122","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1182\/blood-2014-04-567065","article-title":"HIF-1\u03b1 can act as a tumor suppressor gene in murine acute myeloid leukemia","volume":"124","author":"Velasco-Hernandez","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.gendis.2023.02.039_bib123","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.2174\/0929867327666200908114411","article-title":"Repurposing of acriflavine to target chronic myeloid leukemia treatment","volume":"28","author":"Nehme","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.gendis.2023.02.039_bib124","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13046-018-0843-y","article-title":"SWATH-MS based quantitative proteomics analysis reveals that curcumin alters the metabolic enzyme profile of CML cells by affecting the activity of miR-22\/IPO7\/HIF-1\u03b1 axis","volume":"37","author":"Monteleone","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"20","key":"10.1016\/j.gendis.2023.02.039_bib125","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/onc.2010.67","article-title":"Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming","volume":"29","author":"Zhao","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib126","doi-asserted-by":"crossref","first-page":"592","DOI":"10.21037\/tcr.2019.03.23","article-title":"Fumarate hydratase deficiency induces chronic myeloid leukemia progression","volume":"8","author":"Li","year":"2019","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.gendis.2023.02.039_bib127","first-page":"727","article-title":"Inhibition of Siah2 ubiquitin ligase by vitamin K3 attenuates chronic myeloid leukemia chemo-resistance in hypoxic microenvironment","volume":"24","author":"Huang","year":"2018","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12013-014-0434-2","article-title":"HIF-\u03b1 promotes chronic myelogenous leukemia cell proliferation by upregulating p21 expression","volume":"72","author":"Chen","year":"2015","journal-title":"Cell Biochem Biophys"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib129","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.2009.24.5860","article-title":"Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome","volume":"28","author":"Larouche","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib130","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1200\/JCO.2009.24.1893","article-title":"Hypoxia-inducible factor-1{alpha}expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib131","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/leu.2014.324","article-title":"GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-\u03baB-dependent induction of HIF-1\u03b1","volume":"29","author":"Chiche","year":"2015","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib132","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1111\/cas.14890","article-title":"Differentiation of Hodgkin lymphoma cells by reactive oxygen species and regulation by heme oxygenase-1 through HIF-1\u03b1","volume":"112","author":"Nakashima","year":"2021","journal-title":"Cancer Sci"},{"issue":"9","key":"10.1016\/j.gendis.2023.02.039_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006628","article-title":"Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma","volume":"13","author":"Shrestha","year":"2017","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib134","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41374-018-0114-8","article-title":"Overexpression of HIF-1\u03b1 contributes to melphalan resistance in multiple myeloma cells by activation of ERK1\/2, Akt, and NF-\u03baB","volume":"99","author":"Tsubaki","year":"2019","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41375-018-0222-x","article-title":"TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1\u03b1 stabilization","volume":"33","author":"Chen","year":"2019","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.gendis.2023.02.039_bib136","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells: perspectives on current status and future directions: AACR Workshop on cancer stem cells","volume":"66","author":"Clarke","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib137","first-page":"469","article-title":"Cancer stem cells and hypoxia-inducible factors (Review)","volume":"53","author":"Tong","year":"2018","journal-title":"Int J Oncol"},{"issue":"10","key":"10.1016\/j.gendis.2023.02.039_bib138","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc3597","article-title":"Unravelling cancer stem cell potential","volume":"13","author":"Beck","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"10.1016\/j.gendis.2023.02.039_bib139","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.gendis.2023.02.039_bib140","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gendis.2023.02.039_bib141","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3892\/or.2016.5293","article-title":"ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1\u03b1","volume":"37","author":"Lee","year":"2017","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.gendis.2023.02.039_bib142","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/bja\/aeu402","article-title":"Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro","volume":"114","author":"Shi","year":"2015","journal-title":"Br J Anaesth"},{"issue":"45","key":"10.1016\/j.gendis.2023.02.039_bib143","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1038\/onc.2009.252","article-title":"Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha","volume":"28","author":"Soeda","year":"2009","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib144","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s11064-012-0879-x","article-title":"The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determining their fates","volume":"37","author":"Zhang","year":"2012","journal-title":"Neurochem Res"},{"issue":"12","key":"10.1016\/j.gendis.2023.02.039_bib145","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1042\/CS20150451","article-title":"Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors","volume":"129","author":"Semenza","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.gendis.2023.02.039_bib146","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fonc.2016.00041","article-title":"Hypoxia and hypoxia-inducible factors in leukemias","volume":"6","author":"Deynoux","year":"2016","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2023.02.039_bib147","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/cdd.2011.109","article-title":"Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential","volume":"19","author":"Heddleston","year":"2012","journal-title":"Cell Death Differ"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib148","doi-asserted-by":"crossref","first-page":"18110","DOI":"10.4238\/2015.December.22.37","article-title":"High expression of HIF-2\u03b1 and its anti-radiotherapy effect in lung cancer stem cells","volume":"14","author":"Sun","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.gendis.2023.02.039_bib149","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s11658-022-00345-5","article-title":"Effect of chronic intermittent hypoxia-induced HIF-1\u03b1\/ATAD2 expression on lung cancer stemness","volume":"27","author":"Hao","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.gendis.2023.02.039_bib150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.critrevonc.2017.02.025","article-title":"Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer","volume":"113","author":"Vadde","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"21","key":"10.1016\/j.gendis.2023.02.039_bib151","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1158\/0008-5472.CAN-11-3666","article-title":"CD24 is an effector of HIF-1-driven primary tumor growth and metastasis","volume":"72","author":"Thomas","year":"2012","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib152","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.pan.2015.05.472","article-title":"Minnelide, a novel drug for pancreatic and liver cancer","volume":"15","author":"Banerjee","year":"2015","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib153","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-07-0463","article-title":"Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha","volume":"7","author":"Koh","year":"2008","journal-title":"Mol Cancer Therapeut"},{"issue":"11","key":"10.1016\/j.gendis.2023.02.039_bib154","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.3390\/ijms22115703","article-title":"Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target","volume":"22","author":"Infantino","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2023.02.039_bib155","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41467-017-01947-w","article-title":"Parkin targets HIF-1\u03b1 for ubiquitination and degradation to inhibit breast tumor progression","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2023.02.039_bib156","article-title":"Liposomal formulation of HIF-1\u03b1 inhibitor echinomycin eliminates established metastases of triple-negative breast cancer","volume":"29","author":"Bailey","year":"2020","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.gendis.2023.02.039_bib157","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1158\/1541-7786.MCR-18-1109","article-title":"HIF inactivation of p53 in ovarian cancer can be reversed by topotecan, restoring cisplatin and paclitaxel sensitivity","volume":"17","author":"Parmakhtiar","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.gendis.2023.02.039_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172961","article-title":"YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1\u03b1 and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells","volume":"874","author":"Hu","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.gendis.2023.02.039_bib159","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1158\/1078-0432.CCR-14-2810","article-title":"Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer","volume":"21","author":"Pham","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gendis.2023.02.039_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113073","article-title":"Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma","volume":"181","author":"Schmidt","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.gendis.2023.02.039_bib161","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12951-021-01117-7","article-title":"Nickel nanoparticle-induced cell transformation: involvement of DNA damage and DNA repair defect through HIF-1\u03b1\/miR-210\/Rad52 pathway","volume":"19","author":"Mo","year":"2021","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"10.1016\/j.gendis.2023.02.039_bib162","doi-asserted-by":"crossref","first-page":"528","DOI":"10.14348\/molcells.2015.0026","article-title":"The histone methyltransferase inhibitor BIX01294 inhibits HIF-1\u03b1 stability and angiogenesis","volume":"38","author":"Oh","year":"2015","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.gendis.2023.02.039_bib163","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1568026619666190122144949","article-title":"Zinc-dependent deacetylase (HDAC) inhibitors with different zinc binding groups","volume":"19","author":"Li","year":"2019","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"10.1016\/j.gendis.2023.02.039_bib164","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/ph13090208","article-title":"Hif-1\u03b1 inhibitors could\u00a0successfully inhibit the progression of differentiated\u00a0thyroid\u00a0cancer in vitro","volume":"13","author":"Kim","year":"2020","journal-title":"Pharmaceuticals"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304223001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304223001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:30:50Z","timestamp":1762450250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304223001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2352304223001058"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2023.02.039","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIF-1\u03b1 signaling: Essential roles in tumorigenesis and implications in targeted therapies","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2023.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}